Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
42%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
THNR
18
HOLDINGS
50%
ALSO IN PBPH
PBPH
57
HOLDINGS
18%
ALSO IN THNR
SECTOR DRIFT (THNR minus PBPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in PBPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.2% | 16.9% | 12.2% |
|
ABBVIE INC | 5.8% | 7.4% | 5.8% |
|
MERCK & CO. INC. | 5.2% | 5.2% | 5.2% |
 |
ASTRAZENECA PLC | 6.1% | 4.8% | 4.8% |
|
AMGEN INC | 6.3% | 4.4% | 4.4% |
THNR Overweight Relative to PBPH
 |
NOVO-NORDISK A/S-SPONS ADR | 8.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.6% |
 |
CHINA PHARMACEUTICAL GROUP | 4.5% |
 |
INNOVENT BIOLOGICS, INC. | 4.3% |
|
REGENERON PHARMACEUTICALS | 4.3% |
|
VIKING THERAPEUTICS, INC. | 4.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.6% |
|
ZEALAND PHARMA A/S | 3.5% |
 |
HANMI PHARM CO LTD | 2.9% |
|
JIANGSU HENGRUI PHARMACEUT-H | 2.4% |
THNR Underweight Relative to PBPH
|
JOHNSON & JOHNSON | -9.3% |
|
ELI LILLY & CO | -4.7% |
 |
NOVARTIS AG | -4.2% |
|
VERTEX PHARMACEUTICALS INC | -2.7% |
|
NOVO NORDISK A/S-B | -2.5% |
|
BRISTOL-MYERS SQUIBB CO | -2.5% |
 |
SANOFI-AVENTIS | -1.9% |
|
GSK PLC | -1.8% |
|
ABBVIE INC | -1.5% |
|
MODERNA, INC. | -1.5% |